Y-mAbs Therapeutics Inc. (YMAB)

5.20

-0.36 (-6.47%)

At close: Mar 03, 2025, 3:59 PM

5.15

-0.85%

After-hours: Mar 03, 2025, 06:41 PM EST

Y-mAbs Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-21.43M	-95.57M	-55.27M	-119.34M	-81.03M	-43.27M	-19.16M	-17.06M
Depreciation & Amortization	735K	839K	782K	396K	166K	29K	n/a	n/a
Stock-Based Compensation	14.45M	25.6M	19.33M	16.14M	4.66M	1.97M	609K	258K
Other Working Capital	-4.59M	-3.44M	1.76M	2.59M	48K	-1.31M	360K	2.52M
Other Non-Cash Items	-1.26M	3.58M	-62.01M	8.71M	43K	97K	-63K	2.28M
Deferred Income Tax	n/a	n/a	1.9M	-576K	n/a	n/a	n/a	n/a
Change in Working Capital	-19.73M	-10.37M	-7.28M	3.44M	2.67M	-47K	2.75M	3.35M
Operating Cash Flow	-27.23M	-75.92M	-102.56M	-91.23M	-73.5M	-41.23M	-15.87M	-11.17M
Capital Expenditures	n/a	n/a	-967K	-175K	-1.97M	-234K	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	62.01M	-2.61M	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	61.04M	-2.79M	-1.97M	-234K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-366K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	100K	84K	589K	2M	n/a	-1M	-258K	n/a
Financial Cash Flow	100K	84K	108.31M	2M	134.7M	98.76M	89.59M	18.97M
Net Cash Flow	-27.13M	-75.8M	66.93M	-92.5M	59.27M	57.36M	73.61M	7.81M
Free Cash Flow	-27.23M	-75.92M	-103.52M	-91.41M	-75.46M	-41.46M	-15.87M	-11.17M